Breast cancer
Results
Phase 3
This trial compared fulvestrant and anastrozole for breast cancer in women who had been through the menopause. It was for women whose breast cancer could not be removed with surgery or had spread to another part of the body.
Recruitment start: 17 October 2012
Recruitment end: 21 July 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John Robertson
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 18 Apr 2018
CRUK internal database number: 9718